SEP 02, 2015 01:30 PM PDT

Bioburden and Biofilm Control in the Pharmaceutical Industry

Presented At Microbiology
Speakers
  • Manager, Sterility Assurance Research Center, Baxter Healthcare
    Biography
      Dr. Pasmore currently manages the Research Center in the Sterility Assurance department at Baxter Healthcare. His research includes biofilm analyses, rapid microbial methods, alternative sterilization techniques and new product development. He formerly has held the position of Assistant Research Professor at Montana State University, Department of Chemical Engineering. In his role at Montana State, he was the Medical Projects Supervisor at the Center for Biofilm Engineering where he studied biofilms in infection and medically systems, such as hemodialysis systems. Additionally, Dr. Pasmore worked as a Senior Engineer at STERIS Corporation where his research involved the evaluation and development of sterilization and decontamination technologies. He has multiple publications and presentations in the field of biofilm research and he is involved in several professional and standards organizations related to bacterial control and sterilization, including the PDA taskforce on BioburdenBiofilm Management.

    Abstract:

    The Pharmaceutical Industry has a diverse set of products all with varying level of microbial risk to patients. On the low risk extreme there are topical pharmaceuticals on the other extreme are the injectable solutions. The higher the risk of patient infection the more controls must be put in place to control microorganism during the manufacturing processes. Pharmaceutical manufacturing companies producing sterile injectables must be ever diligent to control bioburden (microorganism present in their manufacturing operations). One of the most challenging aspects of that bioburden, and one of the least understood, is that of biofilms. Biofilms create challenges related to harborage, detection, and remediation of the bioburden present in manufacturing operations. This talk will discuss some of the challenges that biofilms create for pharmaceutical manufacturing, as well as some of the current practices to remediate these issues.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    Loading Comments...
    Show Resources